Daniel S. Williamson

4.7k citations

73 papers · 3.3k · 1 hit paper · h-index 30

Impact in

Genetics top 1%
- Glioma Diagnosis and Treatment
Cancer Research top 5%
- Cancer Genomics and Diagnostics

Papers in

Genetics 22
- Glioma Diagnosis and Treatment 22
Cancer Research 13
- Cancer-related molecular mechanisms research 6
- Cancer Genomics and Diagnostics 4

Co-authors: Steven C. Clifford (18 shared papers)Simon R. Bailey (14 shared papers)Ed C. Schwalbe (13 shared papers)Janet C. Lindsey (8 shared papers)JANET M. SHIPLEY (7 shared papers)Stephen Crosier (8 shared papers)Kathy Pritchard‐Jones (5 shared papers)Thomas S. Jacques (6 shared papers)
Journals: Acta Neuropathologica (7 papers)Neuro-Oncology (6 papers)Neuropathology and Applied Neurobiology (3 papers)EBioMedicine (2 papers)BMJ Open (2 papers)
Partner nations: United Kingdom United States Australia

In The Last Decade

Daniel S. Williamson

72 papers receiving 3.3k citations

Daniel S. Williamson's Hit Papers

align trajectories log scale

Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study 2017 · 411 citations

What are hit papers?

Paper score: A paper's citations measured against the top-1% bar of its own field and year: the square root of citations ÷ bar, so 1 means right at the bar and 2 means four times its citations. The bar blends the citation counts that enter the top 1% of the paper's subfields in its year (weighted 89.5%), of those subfields over all years (0.5%) and of its year across all fields (10%); a subfield and year with fewer than 400 papers takes its year's bar. Papers from 2026 are not scored yet: in an unfinished year, when a paper appeared matters more than how it is cited.

Hit paper: A paper cited at least 1.5× the top-1% bar of its field and year: a paper score of at least √1.5.

2017 The Lancet Oncology

Peers

Countries citing papers authored by Daniel S. Williamson

Since Specialization

Citations

This map shows the geographic impact of Daniel S. Williamson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel S. Williamson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel S. Williamson more than expected).

Fields of papers citing papers by Daniel S. Williamson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel S. Williamson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel S. Williamson. The network helps show where Daniel S. Williamson may publish in the future.

Co-authors

The 25 scholars most cited alongside Daniel S. Williamson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daniel S. Williamson Line = papers co-authored together Daniel S. Williamson links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 73 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study The Lancet Oncology ·Ed C. Schwalbe, Janet C. Lindsey, Sirintra Nakjang, Stephen Crosier, Amanda J Smith, Debbie Hicks, Gholamreza Rafiee, Rebecca M. Hill Hit paper breakdown →	2017	411
2	Locoregionally administered B7-H3-targeted CAR T cells for treatment of atypical teratoid/rhabdoid tumors Nature Medicine ·Johanna Lena Theruvath, Elena Sotillo, Christopher Mount, Claus Moritz Graef, Alberto Delaidelli, Sabine Heitzeneder, Louai Labanieh, Shaurya Dhingra	2020	239
3	Second-generation molecular subgrouping of medulloblastoma: an international meta-analysis of Group 3 and Group 4 subtypes Acta Neuropathologica ·Tanvi S. Sharma, Ed C. Schwalbe, Daniel S. Williamson, Martin Sill, Volker Hovestadt, Martin Mynarek, Stefan Rutkowski, Giles W Robinson	2019	215
4	Combined MYC and P53 Defects Emerge at Medulloblastoma Relapse and Define Rapidly Progressive, Therapeutically Targetable Disease Cancer Cell ·Rebecca M. Hill, Sanne J. M. Kuijper, Janet C. Lindsey, Kevin R. Petrie, Ed C. Schwalbe, Karen T. Barker, Jessica K.R. Boult, Daniel S. Williamson	2014	165
5	Molecular subgrouping of atypical teratoid/rhabdoid tumors—a reinvestigation and current consensus Neuro-Oncology ·Ben Ho, Pascal David Johann, Yura Grabovska, Mamy Jean De Dieu Andrianteranagna, Fupan Yao, Michael Christoph Frühwald, Martin Hasselblatt, Franck Bourdeaut	2019	156
6	Pediatric pan-central nervous system tumor analysis of immune-cell infiltration identifies correlates of antitumor immunity Nature Communications ·Yura Grabovska, Alan G. Mackay, Patricia O’Hare, Stephen Crosier, Martina Anna Finetti, Ed C. Schwalbe, Jessica C. Pickles, Amy R. Fairchild	2020	156
7	Depletion of RUNX1/ETO in t(8;21) AML cells leads to genome-wide changes in chromatin structure and transcription factor binding Leukemia ·Anetta Ptasinska, Salam Adli Assi, Deepak Mannari, Sally R. James, Daniel S. Williamson, Jenny Dunne, Maarten Hoogenkamp, Mengchu Wu	2012	144
8	DNA methylation profiling of medulloblastoma allows robust subclassification and improved outcome prediction using formalin-fixed biopsies Acta Neuropathologica ·Ed C. Schwalbe, Daniel S. Williamson, Janet C. Lindsey, Dolores Mary Hamilton, Sarra L. Ryan, Hisham Megahed, Miklós Garami, Péter Hauser	2013	135
9	Relationship Between MYCN Copy Number and Expression in Rhabdomyosarcomas and Correlation With Adverse Prognosis in the Alveolar Subtype Journal of Clinical Oncology ·Daniel S. Williamson, Yong‐Jie Lu, Tony Gordon, Raf Sciot, Anna M. Kelsey, Cyril Fisher, Christopher Poremba, John Anderson	2005	111
10	Genomic imbalances in rhabdomyosarcoma cell lines affect expression of genes frequently altered in primary tumors: An approach to identify candidate genes involved in tumor development Genes Chromosomes and Cancer ·Edoardo Missiaglia, Joanna Selfe, Mohamed Habib Hamdi, Daniel S. Williamson, Gerben Schaaf, Cheng Fang, Jan Köster, Brenda M. Summersgill	2009	92
11	MYC family amplification and clinical risk-factors interact to predict an extremely poor prognosis in childhood medulloblastoma Acta Neuropathologica ·Sarra L. Ryan, Ed C. Schwalbe, Michael F Cole, Yuan Lu, Meryl E. Lusher, Hisham Megahed, Kieran O’Toole, Sarah Leigh Nicholson	2011	83
12	Role for Amplification and Expression of Glypican-5 in Rhabdomyosarcoma Cancer Research ·Daniel S. Williamson, Joanna Selfe, Tony Gordon, Yong‐Jie Lu, Kathy Pritchard‐Jones, Kasumi Murai, Philip H. Jones, Paul Workman	2007	82
13	DNA methylation-based profiling for paediatric CNS tumour diagnosis and treatment: a population-based study The Lancet Child & Adolescent Health ·Jessica C. Pickles, Amy R. Fairchild, T. J. Stone, Lorelle Brownlee, Ashirwad Merve, Shireena A. Yasin, Aimee Avery, Saira Waqar Ahmed	2019	74
14	Acute B lymphoblastic leukaemia‐propagating cells are present at high frequency in diverse lymphoblast populations EMBO Molecular Medicine ·Klaus Rehe, Kerrie Wilson, Simon N. Bomken, Daniel S. Williamson, Julie Anne Elizabeth Irving, Monique L. den Boer, Martin Stanulla, Martin Schrappe	2012	71
15	Comprehensive Analysis of Chromatin States in Atypical Teratoid/Rhabdoid Tumor Identifies Diverging Roles for SWI/SNF and Polycomb in Gene Regulation Cancer Cell ·Serap Erkek, Pascal David Johann, Martina Anna Finetti, Yiannis Drosos, Hsien-Chao Chou, Marc Zapatka, Dominik Sturm, David Jones	2018	68
16	Time, pattern, and outcome of medulloblastoma relapse and their association with tumour biology at diagnosis and therapy: a multicentre cohort study The Lancet Child & Adolescent Health ·Rebecca M. Hill, Stacey Richardson, Ed C. Schwalbe, Debbie Hicks, Janet C. Lindsey, Stephen Crosier, Gholamreza Rafiee, Yura Grabovska	2020	65
17	Comparative expressed sequence hybridization to chromosomes for tumor classification and identification of genomic regions of differential gene expression Proceedings of the National Academy of Sciences ·Yong‐Jie Lu, Daniel S. Williamson, Jeremy Clark, Rubin Wang, Nicki Tiffin, Lorraine Skelton, Tony Gordon, Richard E Williams	2001	48
18	TERT promoter mutation and aberrant hypermethylation are associated with elevated expression in medulloblastoma and characterise the majority of non-infant SHH subgroup tumours Acta Neuropathologica ·Janet C. Lindsey, Ed C. Schwalbe, Sandeep Potluri, Simon R. Bailey, Daniel S. Williamson, Steven C. Clifford	2013	48
19	Medulloblastoma group 3 and 4 tumors comprise a clinically and biologically significant expression continuum reflecting human cerebellar development Cell Reports ·Daniel S. Williamson, Ed C. Schwalbe, Debbie Hicks, Kimberly A. Aldinger, Janet C. Lindsey, Stephen Crosier, Stacey Richardson, Jack Goddard	2022	48
20	Dual Targeting of PDGFRα and FGFR1 Displays Synergistic Efficacy in Malignant Rhabdoid Tumors Cell Reports ·Jocelyn P.-M. Wong, Jason R. Todd, Martina Anna Finetti, Frank M. McCarthy, Malgorzata Broncel, Simon Vyse, Maciej T. Luczynski, Stephen Crosier	2016	47

About Daniel S. Williamson

Daniel S. Williamson is a scholar working on Genetics, Cancer Research, Molecular Biology, Pathology and Forensic Medicine and Hematology, having authored 73 papers that have together received 3.3k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (22 papers), Chromatin Remodeling and Cancer (13 papers), Cancer-related molecular mechanisms research (6 papers), Epigenetics and DNA Methylation (6 papers), Cancer Mechanisms and Therapy (5 papers), Sarcoma Diagnosis and Treatment (5 papers), Cancer Genomics and Diagnostics (4 papers) and Protein Degradation and Inhibitors (4 papers). The work is most often cited by research in Genetics (1.1k citations), Cancer Research (511 citations), Molecular Biology (1.7k citations), Neurology (318 citations) and Oncology (492 citations). Daniel S. Williamson has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Steven C. Clifford, Simon R. Bailey, Ed C. Schwalbe, Janet C. Lindsey, JANET M. SHIPLEY, Stephen Crosier, Kathy Pritchard‐Jones, Thomas S. Jacques, Rebecca M. Hill and Abhijit R. Joshi. Their work appears in journals such as Acta Neuropathologica, Neuro-Oncology, Neuropathology and Applied Neurobiology, EBioMedicine and BMJ Open.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Daniel S. Williamson

Impact in

Papers in i

In The Last Decade

Daniel S. Williamson

Daniel S. Williamson's Hit Papers

Peers

Countries citing papers authored by Daniel S. Williamson

Fields of papers citing papers by Daniel S. Williamson

All Works

About Daniel S. Williamson

Explore authors with similar magnitude of impact

Papers in